How HBV RNA and HBcrAg Relate to cccDNA Transcriptional Activity - Barbara Testoni

International Workshop on HBV Cure 2022

HBV-Specific T Cell Profile Associated with Functional Cure - Georg Lauer

International Workshop on HBV Cure 2022

Why We Should Be Careful Using NA Withdrawal as a Therapeutic Option - Pietro Lampertico

International Workshop on HBV Cure 2022

Therapy Induced Flares Associated With HBsAg Decline - Man-Fung Yuen

International Workshop on HBV Cure 2022

Toxicity Profiles of Checkpoint Inhibition, What to Expect and When to Be Concerned - Morven Cunningham

International Workshop on HBV Cure 2022

What to Watch Preclinical Therapeutics with Novel Mechanisms of Action - Massimo Levrero

International Workshop on HBV Cure 2022

Is Therapy-Induced HBs Decline the Same as Naturally Low HBs? - Jordan Feld

International Workshop on HBV Cure 2022

Séroprévalence du virus de l’hépatite D (VHD) chez des patients porteurs chroniques de l’antigène HBs du virus de l’hépatite B (VHB) à Abidjan de janvier 2017 à Aout 2021 (COTE-D’IVOIRE) - Jean-Louis Philippe N'Din

Conference on Liver Disease in Africa (COLDA) 2022

Cirrhosis Management in Resource Constraint Environments - Mark Sonderup, B Pharm, MBChB, FCP(SA), Mmed

Conference on Liver Disease in Africa (COLDA) 2022

Long-Term Follow-up in Liver Transplant Recipients: First Local Experience - Nabil Debzi

Conference on Liver Disease in Africa (COLDA) 2022

Liver Transplantation Egypt/SA Model - Cote d’Ivore - Elie Keli

Conference on Liver Disease in Africa (COLDA) 2022

Liver Transplantation Egypt/SA Model - Cote d’Ivore - Amr Abdelaal, MD, FACS

Conference on Liver Disease in Africa (COLDA) 2022

Liver Surgery - Eduard Jonas, MB, ChB, MMed, FCS, PhD

Conference on Liver Disease in Africa (COLDA) 2022

HCV Case - Understanding Patterns of Hepatitis C Transmission in a Rural Community - Elizabeth Gatley, MBChB, FCP (SA)

Conference on Liver Disease in Africa (COLDA) 2022

HBV Case - When is it NOT Acute Hepatitis B? - Sandy Mosenye, Bsc( Med Science), MBChB, MMed, FCP(SA)

Conference on Liver Disease in Africa (COLDA) 2022

State-of-the-Art Lecture: HBV Cure - Geoffrey Dusheiko, MBBS, FCP(SA) FRCS

Conference on Liver Disease in Africa (COLDA) 2022

An Assessment of Metabolic Syndrome and Cardiovascular Risk Scores Among Patients With Non-alcoholic Fatty Liver Disease (NAFLD) at the Cape Coast Teaching Hospital, Ghana - Ansumana Bockarie

Conference on Liver Disease in Africa (COLDA) 2022

Prevalence and Mortality Trends of Hepatitis B and Hepatitis C Infection in Sub-Saharan Africa: A Systematic Analysis for the Global Burden of Disease Study 2020 - Hannah Han

Conference on Liver Disease in Africa (COLDA) 2022

Performance-Based Approach to Accelerate Hepatitis C Elimination in Rwanda - Janvier Serumondo

Conference on Liver Disease in Africa (COLDA) 2022

Hepatitis C Laboratory Data Analysis on Patients Seeking Medical Attention in the Public Health Sector, South Africa, 2017-2021 - Morubula J Manamela

Conference on Liver Disease in Africa (COLDA) 2022

Hepatitis Delta Virus Co/Super-Infection Surveillance among Clinicians: An Often- Neglected Practice in Nigeria - Ijeoma Ifeorah

Conference on Liver Disease in Africa (COLDA) 2022

Hepatitis B Infection Prevalence, Genotype Distribution, and Knowledge of Mother- To-Child Transmission Among Antenatal Care Attendees in Yako, Rural Burkina Faso - Serge Ouoba

Conference on Liver Disease in Africa (COLDA) 2022

Hepatitis B Birth Dose Coverage Remains Dramatically Low in the Gambia and Has Been Disrupted by the COVID-19 Pandemic - Gibril Ndow

Conference on Liver Disease in Africa (COLDA) 2022

5-Year Results of a Treatment Program for Chronic Hepatitis B in Ethiopia - Hailemichael Desalegn Mekonnen

Conference on Liver Disease in Africa (COLDA) 2022